Clinical Trial Update: TTA in Treatment of Diabetes and Dyslipidemia [Phase 2]

View source ↗

Summary

Phase 2 trial of TTA for treatment of Type 2 Diabetes Mellitus and Dyslipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Haukeland University Hospital | Conditions: Type 2 Diabetes Mellitus, Dyslipidemia | Phase 2 | Status: COMPLETED